APA (7th ed.) Citation

Moiola, L., Barcella, V., Benatti, S., Capobianco, M., Capra, R., Cinque, P., . . . Riva, A. (2021). The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. Multiple sclerosis, 27(3), 331. https://doi.org/10.1177/1352458520952311

Chicago Style (17th ed.) Citation

Moiola, Lucia, et al. "The Risk of Infection in Patients with Multiple Sclerosis Treated with Disease-modifying Therapies: A Delphi Consensus Statement." Multiple Sclerosis 27, no. 3 (2021): 331. https://doi.org/10.1177/1352458520952311.

MLA (9th ed.) Citation

Moiola, Lucia, et al. "The Risk of Infection in Patients with Multiple Sclerosis Treated with Disease-modifying Therapies: A Delphi Consensus Statement." Multiple Sclerosis, vol. 27, no. 3, 2021, p. 331, https://doi.org/10.1177/1352458520952311.